Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Advanced Solid Tumors That Are MTAP Deficient
Chengdu
Advanced Solid Tumors That Are MTAP Deficient Clinical Trials in Chengdu
1 recruiting
Chengdu, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
Advanced Solid Tumors That Are MTAP Deficient
AstraZeneca
334 enrolled
21 locations
NCT06130553
Feedback